Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.25.3
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Series A Convertible Preferred Stock [Member]
Beginning balance, value at Dec. 31, 2023 $ 0   $ 101,175,117 $ (120,806,138) $ (19,631,021) $ 0
Beginning balance, shares at Dec. 31, 2023 162         0
Issuance of common stock for exercise of pre-funded warrants  
Issuance of common stock for exercise of pre-funded warrants, shares 28,293          
Issuance of common stock for exercise of Series A warrants   17,352,653 17,352,653
Issuance of common stock for exercise of Series A warrants, shares 2,166          
Proceeds received for exercise of buydown warrants   3,500 3,500
Proceeds received for exercise of buydown warrants, shares 2          
Common stock issued for conversion of convertible notes   7,395,907 7,395,907
Common stock issued for conversion of convertible notes, shares 622          
Conversion of Convertible Notes   24,716,118 24,716,118
Conversion of Convertible Notes, shares           24,698
Conversion of Preferred Stock for common stock  
Conversion of Preferred Stock for common stock, shares 34,881         (24,698)
Issuance of common stock for exercise of Series B Warrants   1 1
Issuance of common stock for exercise of Series B Warrants, shares 1,838          
Reclassification of warrant liability to equity   3,405,662 3,405,662
Proceeds received for Issuance of warrants with May 2024 Notes, net of issuance costs of $111,194   1,023,200 1,023,200
Issuance of common stock and pre-funded warrants, net of issuance costs of $1,210,753   10,789,261 10,789,261
Issuance of common stock and pre-funded warrants, net of issuance costs, shares 12,826          
Stock-based compensation   295,882 295,882
Common stock issued for reverse stock split due to rounding  
Common stock issued for reverse stock split due to rounding, shares 1,431          
Net loss   (40,292,940) (40,292,940)
Ending balance, value at Sep. 30, 2024 $ 0   166,157,301 (161,099,078) 5,058,223 $ 0
Ending balance, shares at Sep. 30, 2024 82,221        
Beginning balance, value at Dec. 31, 2024 $ 1 $ 0 166,357,207 (166,316,447) 40,761  
Beginning balance, shares at Dec. 31, 2024 78,859          
Beginning balance, shares at Dec. 31, 2024   0        
Issuance of common stock for exercises of pre-funded warrants $ 25 $ 0 (25) 0 0  
Issuance of common stock for exercises of pre-funded warrants, shares 2,538,064          
Issuance of common stock from the At the Money offering, net of issuance costs of $374,392 $ 3 10,288,059 10,288,062  
Issuance of common stock from the At the Money offering, net of issuance costs, shares 356,568          
Issuance of common stock and pre-funded warrants, net of issuance costs of $1,210,753 $ 1 10,703,881 10,703,882  
Issuance of common stock and pre-funded warrants, net of issuance costs, shares 53,750          
Issuance of common stock for disputed shares from November 2024 reverse stock split (see Note 2) $ 0 0 0 0 0  
Issuance of common stock for disputed shares from November 2024 reverse stock split, shares 23,617          
Purchase fractional shares (941) (941)  
Purchase fractional shares, shares (179)          
Exchange of common stock for pre-funded warrants $ 0 0 0 0 0  
Exchange of common stock for pre-funded warrants, shares (4,323)          
Issuance of common stock and pre-funded warrants, net of issuance costs of $21,136,401 $ 444 480,291,610 480,292,054  
Issuance of common stock and pre-funded warrants, net of issuance costs, shares 44,414,189          
Issuance of common stock for exercises of warrants $ 1 1,783,999 1,784,000  
Issuance of common stock for exercises of warrants, shares 111,500          
Stock-based compensation 14,855,030 14,855,030  
Repurchases of common stock for treasury stock $ (39,406,458) (39,406,458)  
Repurchases of common stock for treasury stock, shares (5,234,166) 5,234,166        
Net loss (40,915,628) (40,915,628)  
Ending balance, value at Sep. 30, 2025 $ 475 $ (39,406,458) $ 684,278,820 $ (207,232,075) $ 437,640,762  
Ending balance, shares at Sep. 30, 2025 42,337,879          
Ending balance, shares at Sep. 30, 2025   5,234,166